Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Br J Sports Med. 2024 May 2;58(10):556-566. doi: 10.1136/bjsports-2023-107849.
To examine and summarise evidence from meta-analyses of cohort studies that evaluated the predictive associations between baseline cardiorespiratory fitness (CRF) and health outcomes among adults.
Overview of systematic reviews.
Five bibliographic databases were searched from January 2002 to March 2024.
From the 9062 papers identified, we included 26 systematic reviews. We found eight meta-analyses that described five unique mortality outcomes among general populations. CRF had the largest risk reduction for all-cause mortality when comparing high versus low CRF (HR=0.47; 95% CI 0.39 to 0.56). A dose-response relationship for every 1-metabolic equivalent of task (MET) higher level of CRF was associated with a 11%-17% reduction in all-cause mortality (HR=0.89; 95% CI 0.86 to 0.92, and HR=0.83; 95% CI 0.78 to 0.88). For incident outcomes, nine meta-analyses described 12 unique outcomes. CRF was associated with the largest risk reduction in incident heart failure when comparing high versus low CRF (HR=0.31; 95% CI 0.19 to 0.49). A dose-response relationship for every 1-MET higher level of CRF was associated with a 18% reduction in heart failure (HR=0.82; 95% CI 0.79 to 0.84). Among those living with chronic conditions, nine meta-analyses described four unique outcomes in nine patient groups. CRF was associated with the largest risk reduction for cardiovascular mortality among those living with cardiovascular disease when comparing high versus low CRF (HR=0.27; 95% CI 0.16 to 0.48). The certainty of the evidence across all studies ranged from very low-to-moderate according to Grading of Recommendations, Assessment, Development and Evaluations.
We found consistent evidence that high CRF is strongly associated with lower risk for a variety of mortality and incident chronic conditions in general and clinical populations.
综述队列研究的荟萃分析证据,评估成年人基线心肺适应能力(CRF)与健康结果之间的预测关联。
系统评价概述。
从 2002 年 1 月至 2024 年 3 月,检索了 5 个文献数据库。
在 9062 篇论文中,我们纳入了 26 篇系统评价。我们发现了 8 项描述一般人群中 5 种独特死亡率结果的荟萃分析。与低心肺适应能力相比,高心肺适应能力的全因死亡率风险降低最大(HR=0.47;95%CI 0.39 至 0.56)。每提高 1 个代谢当量(MET)的心肺适应能力水平,全因死亡率降低 11%-17%(HR=0.89;95%CI 0.86 至 0.92,和 HR=0.83;95%CI 0.78 至 0.88)存在剂量反应关系。对于新发结局,9 项荟萃分析描述了 12 种独特结局。与低心肺适应能力相比,高心肺适应能力的新发心力衰竭风险降低最大(HR=0.31;95%CI 0.19 至 0.49)。每提高 1-MET 的心肺适应能力水平,心力衰竭风险降低 18%(HR=0.82;95%CI 0.79 至 0.84)。在患有慢性病的人群中,9 项荟萃分析在 9 个患者组中描述了 4 种独特结局。与低心肺适应能力相比,高心肺适应能力的心血管疾病患者心血管死亡率风险降低最大(HR=0.27;95%CI 0.16 至 0.48)。根据推荐、评估、制定和评估分级,所有研究的证据确定性范围从极低到中等。
我们发现了一致的证据,表明高心肺适应能力与一般人群和临床人群各种死亡率和新发慢性病的风险降低密切相关。